Patents by Inventor Colin Bier

Colin Bier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of Inflammation, Autoimmune, and Neurodegenerative Disorders with Immunosuppressive Tat Derivative Polypeptides
    Publication number: 20210069290
    Abstract: The present specification provides immunosuppressive Tat derivative polypeptides, compositions, and methods of using such polypeptides and compositions to treat an autoimmune disease, an inflammation-associated disease and/or a neurodegenerative disease.
    Type: Application
    Filed: November 18, 2020
    Publication date: March 11, 2021
    Inventors: Joshua Goldberg, Colin Bier, Christoph Hotz-Behofsits, Sophie Hanscom
  • TREATMENT OF CANCERS WITH IMMUNOSTIMULATORY HIV TAT DERIVATIVE POLYPEPTIDES
    Publication number: 20190030117
    Abstract: Disclosed herein are compositions comprising a Human Immunodeficiency Virus (HIV) trans-activator of transcription (Tat) derivative polypeptide with increased immunostimulatory properties relative to the native Tat polypeptide, pharmaceutical compositions comprising the Tat derivative polypeptide, and methods of treating cancer using the Tat derivative polypeptide.
    Type: Application
    Filed: October 16, 2018
    Publication date: January 31, 2019
    Inventors: Joshua Goldberg, Colin Bier
  • Treatment of cancers with immunostimulatory HIV Tat derivative polypeptides
    Patent number: 10159707
    Abstract: Disclosed herein are compositions comprising a Human Immunodeficiency Virus (HIV) trans-activator of transcription (Tat) derivative polypeptide with increased immunostimulatory properties relative to the native Tat polypeptide, pharmaceutical compositions comprising the Tat derivative polypeptide, and methods of treating cancer using the Tat derivative polypeptide.
    Type: Grant
    Filed: May 4, 2017
    Date of Patent: December 25, 2018
    Assignee: PIN Pharma, Inc.
    Inventors: Joshua Goldberg, Colin Bier
  • Treatment of Inflammation, Autoimmune, and Neurodegenerative Disorders with Immunosuppressive Tat Derivative Polypeptides
    Publication number: 20180185441
    Abstract: The present specification provides immunosuppressive Tat derivative polypeptides, compositions, and methods of using such polypeptides and compositions to treat an autoimmune disease, an inflammation-associated disease and/or a neurodegenerative disease.
    Type: Application
    Filed: December 21, 2017
    Publication date: July 5, 2018
    Inventors: Joshua Goldberg, Colin Bier, Christoph Hotz-Behofsits, Sophie Hanscom
  • Immunosuppressive Tat derivative polypeptides
    Patent number: 9878001
    Abstract: The present specification provides immunosuppressive Tat derivative polypeptides, compositions, and methods of using such polypeptides and compositions to treat an autoimmune disease, an inflammation-associated disease and/or a neurodegenerative disease.
    Type: Grant
    Filed: December 6, 2013
    Date of Patent: January 30, 2018
    Assignee: PIN Pharma, Inc.
    Inventors: Joshua Goldberg, Colin Bier, Christoph Hotz-Behofsits, Sophie Hanscom
  • TREATMENT OF CANCERS WITH IMMUNOSTIMULATORY HIV TAT DERIVATIVE POLYPEPTIDES
    Publication number: 20170274040
    Abstract: Disclosed herein are compositions comprising a Human Immunodeficiency Virus (HIV) trans-activator of transcription (Tat) derivative polypeptide with increased immunostimulatory properties relative to the native Tat polypeptide, pharmaceutical compositions comprising the Tat derivative polypeptide, and methods of treating cancer using the Tat derivative polypeptide.
    Type: Application
    Filed: May 4, 2017
    Publication date: September 28, 2017
    Inventors: Joshua Goldberg, Colin Bier
  • Treatment of cancers with immunostimulatory HIV tat derivative polypeptides
    Patent number: 9663556
    Abstract: Disclosed herein are compositions comprising a Human Immunodeficiency Virus (HIV) trans-activator of transcription (Tat) derivative polypeptide with increased immunostimulatory properties relative to the native Tat polypeptide, pharmaceutical compositions comprising the Tat derivative polypeptide, and methods of treating cancer using the Tat derivative polypeptide.
    Type: Grant
    Filed: October 3, 2014
    Date of Patent: May 30, 2017
    Assignee: PIN Pharma, Inc.
    Inventors: Joshua Goldberg, Colin Bier
  • TREATMENT OF CANCERS WITH IMMUNOSTIMULATORY HIV TAT DERIVATIVE POLYPEPTIDES
    Publication number: 20150098960
    Abstract: Disclosed herein are compositions comprising a Human Immunodeficiency Virus (HIV) trans-activator of transcription (Tat) derivative polypeptide with increased immunostimulatory properties relative to the native Tat polypeptide, pharmaceutical compositions comprising the Tat derivative polypeptide, and methods of treating cancer using the Tat derivative polypeptide.
    Type: Application
    Filed: October 3, 2014
    Publication date: April 9, 2015
    Inventors: Joshua Goldberg, Colin Bier
  • Treatment of Inflammation, Autoimmune, and Neurodegenerative Disorders with Immunosuppressive Tat Derivative Polypeptides
    Publication number: 20140178420
    Abstract: The present specification provides immunosuppressive Tat derivative polypeptides, compositions, and methods of using such polypeptides and compositions to treat an autoimmune disease, an inflammation-associated disease and/or a neurodegenerative disease.
    Type: Application
    Filed: December 6, 2013
    Publication date: June 26, 2014
    Applicant: PIN Pharma, Inc.
    Inventors: Joshua Goldberg, Colin Bier, Christoph Hotz-Behofsits, Sophie Hanscom